CorMedix’s CRMD lead product, DefenCath (taurolidine plus heparin), is the company’s primary source of revenues. DefenCath ...

The Pitt season premiere, "7:00 a.m.," ignores clichés in favor of a gritty, realistic, and uncompromising take on the ...

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.

Up to 189 health conditions could potentially affect your ability to drive, with seven specific conditions that must be ...

As many as 189 health conditions could potentially affect your legal ability to drive. Both physical and mental health ...

Drivers could face up to £1,000 fines and potential prosecution if they fail to report notifiable medical conditions or ...

Drivers could be hit with £1,000 fine for wrongly declaring their condition and may also face prosecution in the event of an ...

CorMedix announces preliminary, unaudited financial results for Q4 and FY 2025, including net revenue of approximately $127 million and $310 million, for Q4 2025 and FY 2025, respectively, FY 2025 Pro ...

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced an ...

Getting wrinkles, fine lines, and creases on your skin is a totally normal part of aging—but if you’re looking to achieve a smoother, more even complexion, it all starts with an anti-aging skincare ...